Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/bestatin-combined induces antinociceptive effects through different opioid mechanisms
References (32)
- et al.
Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor
Eur J Pharmacol
(1983) - et al.
A novel bovine spinal cord endoprotease with high specificity for dynorphin B
J Biol Chem
(1989) - et al.
Characterization of dynorphin A-converting enzyme in human spinal cord
- et al.
Inhibition of dynorphinconverting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test
Eur J Pharmacol
(1996) - et al.
The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord
Neuropharmacology
(1992) - et al.
Antinociception induced by CP 96, 345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin tests
Neurosci Lett
(1993) - et al.
Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice
Eur J Pharmacol
(1993) - et al.
Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test
Brain Res
(1994) - et al.
Effect of spinal nitric oxide inhibition on capsaicin-induced nociceptive response
Life Sci
(1996) - et al.
Formalin test in mice, a useful technique for evaluating mild analgesics
J Neurosci Meth
(1985)
Multiple opioid systems and pain
Pain
Levels of dynorphin peptides in the central nervous system and pituitary gland of the spontaneously hypertensive rat
Neurochem Int
Dynorphin: potent analgesic effect in spinal cord of the rat
Life Sci
Analgesia induced by intrathecal injection of dynorphin B in the rat
Life Sci
Characterization of dynorphin A-induced antinociception at spinal level
Eur J Pharmacol
Enkephalins interact with substance P-induced aversive behaviour in mice
Brain Res
Cited by (14)
Inhibitors of neuropeptide peptidases engaged in pain and drug dependence
2020, NeuropharmacologyCitation Excerpt :Moreover, it was observed that the analgesic effect of phosphoramidon in combination with bestatin have been antagonized by the selective δ-opioid receptor antagonist naltrindole, but not by κ-opioid receptor antagonist nor-binaltorphimine. This may suggest that antinociception induced by phosphoramidon is not directly connected to the inhibition of DCEs, but rather blocks the degradation of endogenous enkephalins in the spinal cord of mouse (Tan-No et al., 1996, 1997, 1998). The ability of amastatin, captopril and/or phosphoramidon in potentiating the inhibitory effect of dynorphin A1–8 on the electrically evoked contractions of guinea-pig ileum, mouse vas deferens and rabbit vas deferens, was also reported in this study.
Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice
2013, NeuropeptidesCitation Excerpt :We have examined the effect of various protease inhibitors on the functions in the central nervous system (CNS). The findings regarding cysteine protease inhibitors that have been found so far are described as follows: (1) p-hydroxymercuribenzoate (PHMB), a general cysteine protease inhibitor, and Boc-Tyr-Gly-NHO-Bz (BYG-Bz), a representative of a novel class of cysteine protease inhibitors, when co-administered with dynorphin A or dynorphin B, significantly prolong antinociception induced by intrathecal (i.t.) and intracerebroventricular (i.c.v.) injection of these dynorphins in the mouse formalin and capsaicin tests (Tan-No et al., 1996, 2001, 2005a); (2) i.t.-administered PHMB produces antinociceptive effect in capsaicin test through the inhibition of endogenous dynorphin degradation (Tan-No et al., 1998); (3) i.t.-administered N-ethylmaleimide, another cysteine protease inhibitor, produces nociceptive behavior through the inhibition of endogenous dynorphin degradation in uninjured mice (Tan-No et al., 2005b); (4) N-ethylmaleimide and BYG-Bz suppress the development of antinociceptive tolerance to morphine, presumably through the inhibition of dynorphin degradation when administered i.t. 5 min before each morphine pretreatment during the induction (Tan-No et al., 2008). These observations indicate that cysteine protease inhibitors modulate CNS pathways engaged in pain transmission and morphine tolerance, through the inhibition of endogenous dynorphin degradation.
Chapter 15 Nociceptive Behavior Induced by the Endogenous Opioid Peptides Dynorphins in Uninjured Mice. Evidence with Intrathecal N-Ethylmaleimide Inhibiting Dynorphin Degradation
2009, International Review of NeurobiologyCitation Excerpt :Once this has been done, dynorphin A could induce allodynia and hyperalgesia to protect the injured area from further damage by immobilizing the injured limb/part of the body and this action is mediated through the NMDA receptors. Differential effects of cysteine protease inhibitors mediated through the dynorphin system support the notion that endogenous dynorphins play antinociceptive and pronociceptive roles in an acute pain state (Tan‐No et al., 1998) and uninjured animals (Tan‐No et al., 2005b), respectively. A consensus of different studies appears to be that the spinal dynorphin system plays an inhibitory role in nociceptive transmission mediated through the κ‐opioid receptor in an acute pain state, and a facilitative role mediated through an NMDA receptor mechanism in a chronic pain state when the κ‐opioid receptor became tolerant due to sustained activation by endogenous dynorphins (Xu et al., 2004).